Lung Cancer Living Room™

The Lung Cancer Living Room™ - Advances in Molecular-Based Therapy - August 21, 2018

Join us for a discussion on Advances in Molecular-Based Therapy for Non-Small-Cell Cancer. Molecular based therapy is an option when lung cancer carries a specific “driver” gene mutation such as in EGFR, ALK, ROS1, BRAF and others. We will discuss the latest technologies to find driver mutations and focus on the quickly advancing treatment options for these subtypes of lung cancer.